Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1,10-phenanthroline | - |
Sus scrofa | |
benzamidine | - |
Sus scrofa | |
chymostatin | - |
Sus scrofa | |
DFP | - |
Sus scrofa | |
EDTA | - |
Sus scrofa | |
Hg2+ | - |
Sus scrofa | |
leupeptin | - |
Sus scrofa | |
Pancreatic trypsin inhibitor | bovine pancreatic trypsin inhibitor | Sus scrofa | |
Zn2+ | - |
Sus scrofa |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
microsome | - |
Sus scrofa | - |
- |
Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|
22400 | - |
x * 22400, SDS-PAGE under nonreducing conditions | Sus scrofa |
28000 | - |
x * 28000, SDS-PAGE under reducing conditions | Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
- |
- |
Purification (Comment) | Organism |
---|---|
enzyme form A and B | Sus scrofa |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
gastric mucosa | antral mucosa | Sus scrofa | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.897 | - |
form B | Sus scrofa |
0.9397 | - |
form A | Sus scrofa |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
tert-butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin 7-amide + H2O | - |
Sus scrofa | ? | - |
? | |
tert-butyloxycarbonyl-Gln-Arg-Arg-4-methylcoumarin 7-amide + H2O | - |
Sus scrofa | ? | - |
? | |
tert-butyloxycarbonyl-Gln-Gly-Arg-4-methylcoumarin 7-amide + H2O | - |
Sus scrofa | ? | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 22400, SDS-PAGE under nonreducing conditions | Sus scrofa |
? | x * 28000, SDS-PAGE under reducing conditions | Sus scrofa |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
8 | 9 | - |
Sus scrofa |